TY - JOUR
T1 - The Emerging Field of Cardioimmunology
T2 - Past, Present and Foreseeable Future
AU - Mann, Douglas L.
PY - 2024/6/7
Y1 - 2024/6/7
N2 - Over the past 30 years, the field of cardioimmunology has moved from being dismissed as a field that was chasing an epiphenomenon of little biological consequence to a scientific discipline that is providing important new insights into the immunologic basis for hypertension, atherosclerosis, myocarditis, pericarditis, autoimmune heart disease, and heart failure. In this article, we will review the conceptual insights and technical breakthroughs that have allowed the field to move forward, as well as the clinical trials in the cardioimmunology space, to provide a historical context for the articles that will appear in the compendium that is focused on the interface between cardioimmunology, myocardial function, and disease.
AB - Over the past 30 years, the field of cardioimmunology has moved from being dismissed as a field that was chasing an epiphenomenon of little biological consequence to a scientific discipline that is providing important new insights into the immunologic basis for hypertension, atherosclerosis, myocarditis, pericarditis, autoimmune heart disease, and heart failure. In this article, we will review the conceptual insights and technical breakthroughs that have allowed the field to move forward, as well as the clinical trials in the cardioimmunology space, to provide a historical context for the articles that will appear in the compendium that is focused on the interface between cardioimmunology, myocardial function, and disease.
KW - atherosclerosis
KW - heart failure
KW - hypertension
KW - myocarditis
KW - pericarditis
UR - http://www.scopus.com/inward/record.url?scp=85195439346&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.123.323656
DO - 10.1161/CIRCRESAHA.123.323656
M3 - Article
C2 - 38843286
AN - SCOPUS:85195439346
SN - 0009-7330
VL - 134
SP - 1663
EP - 1680
JO - Circulation research
JF - Circulation research
IS - 12
ER -